Isabelle Scarabin is a Director, Business Development & Licensing Officer, at the Pharmaceuticals division of Bayer AG since November 2021. She leads the development of strategies and projects as related to business development for New Platforms (Cell & Gene Therapy), Ophthalmology, Cardiovascular and Immunology.

Isabelle is a senior Business Development manager with 17+ years of experience in the Healthcare industry. Since 2013, she was the Business Development Director at GenSight Biologics, a French public company, developing and commercializing gene therapies for rare degenerative diseases. Prior to GenSight, Isabelle had 10+ years of consulting experience in non-profit organizations in business development for biotech firms. She started her career in innovation management at Resources in Innovation and in new vaccine launch management and strategic marketing at Sanofi Pasteur MSD.

Isabelle received a double master’s degree in Biochemistry Engineering from the National Institute of Applied Sciences (INSA) Lyon and in Innovation & Technology Management from EMLyon Business School.